You may have seen the news (7th June 2021) that the American FDA (Food and Drug Agency) has approved aducunamab (Aduhelm) for the treatment of mild Alzheimer’s Disease. This is the first new treatment for Alzheimer’s Disease licensed in some 20 years but is not yet licensed or available for use in the UK and we […]
RICE is pleased to have places in the twice (!) rearranged Bath Half Marathon 2021/2.
We have been delighted with the very positive response from both patients and their families to our popular therapy study PrAISED